Ligand Pharma (LGND) Prices $225M in Conv. Senior Notes; to Buyback ~700K Shares
Tweet Send to a Friend
Ligand Pharma (NASDAQ: LGND) announced the pricing of $225 million aggregate principal amount of 0.75% convertible senior notes due 2019 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
